tasly pharmaceuticals co ltd
Tasly Pharma To Conduct Phase III Angina Pectoris Trials For Its Dantonic Pill
Tasly Pharma is conducting two global Phase III trials for T89, also known as the Dantonic® pill, that the company hopes will become the first traditional Chinese medicine to receive FDA approval in the United States.



